In today’s competitive and unpredictable allogeneic cell therapy landscape, a strong donor screening strategy creates a true competitive edge. To support this, biotech and pharma companies are in search of solution providers they can trust to provide excellent account management and reliable, high-quality services.
From our market research, leading industry experts in the field have mentioned they need help from service providers and require meaningful partnerships to aid with characterization testing, donor recruitment and management, viral testing, provide high quality leukopaks and apheresis services and more!
This is the ONLY meeting dedicated entirely to tackling the challenges of donor variability in allogeneic therapies. Take advantage of this unique opportunity to connect with experts from biotech, pharma, and academia across process development, analytical development, supply chain, and more.
Why Become a Partner?
Showcase your leadership in donor screening and variability for allogeneic therapies by engaging with a focused audience of decision-makers from pharma, biotech, and academia
Drive partnerships and build your reputation as a go-to collaborator in shaping the future of allogeneic cell therapies
Stand out from the competition by aligning your brand with the only conference dedicated to tackling donor variability with cutting-edge science and practical solutions
Who Will You Meet?
Join Our Current Sponsors:
Explore Related Events
Introducing the Cell Therapies Event Series, a collection of 26 established events curated to enable this community to achieve their clinical and commercial potential.
Having trouble downloading the brochure? Let us know here and we'll email it to you instead.
Download the Partnership Prospectus to see:
26 Events in the Series
Bespoke Partnerships Opportunities
Audience Breakdown
Creative Branding Options